Progyny Inc at Bank of America Merrill Lynch Global Healthcare Conference Transcript

Sep 15, 2022 / 09:50AM GMT
Michael Aaron Cherny - BofA Securities, Research Division - Director

Well, thank you, everyone, and welcome to this session of the BofA Global Healthcare Conference. With me today -- I'm Michael Cherny, the healthcare tech and distribution analyst at BofA. Much more importantly that we have the Progyny management team. Peter Anevski, CEO; Mark Livingston, CFO. I know they both take on many more roles and many more hats beyond that, but at least from a official title perspective.

Questions and Answers:

Michael Aaron Cherny - BofA Securities, Research Division - Director

We don't have any slides today, so we're going to go to a fireside chat, but maybe just pet to level set for anyone who is listening for the first time, what is Progyny, from a very base level perspective?

Peter Anevski - Progyny, Inc. - CEO & Director

Sure. Progyny is a carve-out benefit for fertility services, reproductive health in the U.S. And basically, in its simplest terms, our approach towards providing fertility as part of your
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot